Home
Conditions
Schizophrenia

Clinical trial condition

Schizophrenia

Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.

2,716 public trials 268 recruiting studies

Refine in advanced search Browse all conditions

Schizophrenia trial results

Completed

Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia

NCT01163227

Conditions: Behavior, Behavioral Symptoms, Cognition Disorders, +13 more
Locations: PAREXEL (California Clinical Trials Medical Group), 1560 Chevy Chase Drive, Suite 140, Glendale, California, United States

CRI Worldwide, 1113 Hospital Dr. Suite 202, Willingboro, New Jersey, United States

View Trial Details

Completed

A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients

NCT01730768

Conditions: Behavior, Mental Disorders, Schizophrenia, +3 more
Locations: Novartis Investigative Site Garden Grove, California, United States

Novartis Investigative Site Glendale, California, United States

Novartis Investigative Site National City, California, United States

Novartis Investigative Site Oakland, California, United States

View all 13 locations

View Trial Details

Completed

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)

NCT02970305

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Phoenix, Arizona, United States

Rogers, Arkansas, United States

Bellflower, California, United States

Lemon Grove, California, United States

View all 101 locations

View Trial Details

Completed

Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia

NCT00176423

Conditions: Cognition Disorders, Cognitive Dysfunction, Mental Disorders, +5 more
Locations: Maryland Psychiatric Research Center Baltimore, Maryland, United States

View Trial Details

Completed

Quetiapine and the Dopaminergic Epigenetic Control

NCT00370500

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Department of Psychiatry and Psychotherapy, University Erlangen-Nuremberg Erlangen, Germany

View Trial Details

Completed

Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults

NCT04187560

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Medpace Clinical Pharmacology LLC Cincinnati, Ohio, United States

View Trial Details

Completed

Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics

NCT02360319

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: La Frontera Tucson, Arizona, United States

San Fernando Mental Health Center Granada Hills, California, United States

Stanford School of Medicine Palo Alto, California, United States

Henderson Behavioral Health Fort Lauderdale, Florida, United States

View all 39 locations

View Trial Details

Completed

Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia

NCT02975973

Conditions: Mental Disorders, Psychosis, Psychotic Disorders, +2 more
Locations: Baylor College of Medicine Houston, Texas, United States

View Trial Details

Completed

Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics

NCT02573168

Conditions: Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
Locations: Centre for Addiction and Mental Health Toronto, Ontario, Canada

View Trial Details

Completed

Level of Immersion of Virtual Reality and Cognition and Motor Performance in Patients of Schizophrenia Spectrum Disorder

NCT04629898

Conditions: Mental Disorders, Multi-tasks, Schizophrenia, +3 more
Locations: National Taiwan Normal University Taipei, Taiwan

View Trial Details

Schizophrenia

Schizophrenia trial results

Related conditions